Recently, the popularity of weight loss drugs (also known as anti-obesity drugs) that help people lose weight has increased and taken the world by storm. In early March, the U.S. Food and Drug Administration (FDA) approved a new use for one of these drugs.

Wigovy (semaglutide) injection, an injectable weight loss drug, has been approved to reduce the risk of cardiovascular events such as heart attack, stroke, and heart-related death in obese or overweight adults with cardiovascular disease. , the report was published. F.D.A.

According to the World Health Organization (WHO), by 2022, 43% of adults over the age of 18 will be overweight and 16% will be living with obesity. According to the Centers for Disease Control and Prevention (CDC), there are many risk factors for heart disease, and obesity is one of them. Obesity is expected to affect 50% of the U.S. population by 2030.

A double-blind, placebo-controlled study of more than 17,600 participants found that Wegovy significantly reduced the risk of cardiovascular events. The results found that 6.5% of participants who received Wegovy experienced a cardiovascular event, compared to 8% of participants who received a placebo.

This study is a landmark trial that provides evidence that weight loss can help prevent cardiovascular disease in at-risk patients. Such evidence has been lacking so far, and this result may not only help encourage the medical community to treat obesity as a disease, but also change the landscape of managing obesity as a true medical condition. . The hope is that insurance plans will recognize the importance of taking these medications to address not only weight loss but also related complications.

A weight-centered philosophy of supporting patients with their weight loss goals and associated symptoms is evident at The Valley Hospital’s Bariatric Surgery and Weight Loss Management Center. Our team works with each patient to create a personalized treatment plan that incorporates one or more weight loss solutions to help them reach their personal goals.

We recognize that each patient has different weight loss needs and goals, so we offer several solutions. From medically supervised weight loss using the latest FDA-approved medications and weight loss clinics to state-of-the-art surgical options such as robot-assisted sleeve gastrectomy and robot-assisted modified duodenal switch, we’re here to help our patients find what they want. We offer several treatment options to help you get the treatment you need. Weight loss choices that are right for them. Through this personalized approach to care, we give our patients the tools to successfully lose weight, maintain their success, and live healthier, more fulfilling lives.

In addition to personalized treatment, our team partners with a variety of clinical teams, including cardiology. primary care. Valley Health Lifestyles, Valley’s medical fitness center, provides education and resources to promote a weight-centered approach to care. This approach recognizes that a healthy weight, diet, and exercise are the foundations of overall health.

For more information about the center, visit ValleyHealth.com/WeightLoss.